472 results on '"Pavelka, K"'
Search Results
2. Circulating miRNAs in hand osteoarthritis
3. Factors associated with the orthopaedic surgeon's decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1905 patients
4. MODERN METHODS OF DOCUMENTATION AND VISUALIZATION OF HISTORICAL MINES IN THE UNESCO MINING REGION IN THE ORE MOUNTAINS
5. DIFFERENT DATA JOINING AS A BASIC MODEL FOR HBIM – A CASE PROJECT ST. PATALEIMON IN SKOPJE
6. ANALYSIS OF POSSIBLE GEODETIC APPROACHES FOR 3D MODEL CREATION IN BIM
7. Associations Of Radiographic Progression With Biochemical Markers And Clinical Assessments In Patients With Hand Osteoarthritis: A 5-Year Longitudinal Cohort Study
8. Corrigendum to 'Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: data from the EuroSpA collaboration' [Seminars in Arthritis and Rheumatism 56 (2022) 1-13/152081]
9. One-Third of European Patients With Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment.
10. CO148 Time in Remission as an Alternative Outcome Measure for Ankylosing Spondylitis: A 4-Year Prospective Study of 1900 Users of Anti-TNF
11. SEX DIFFERENCES IN EFFECTIVENESS OF FIRST-LINE TUMOR NECROSIS FACTOR INHIBITORS IN PSORIATIC ARTHRITIS; RESULTS FROM THIRTEEN COUNTRIES IN THE EUROSPA RESEARCH COLLABORATION NETWORK
12. CAN SINGLE IMPUTATION TECHNIQUES FOR BASDAI COMPONENTS RELIABLY CALCULATE THE COMPOSITE SCORE IN AXIAL SPONDYLOARTHRITIS PATIENTS?
13. ANALYSIS OF DATA JOINING FROM DIFFERENT INSTRUMENTS FOR OBJECT MODELLING
14. European bio-naïve spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and response
15. GATHERING GEODATA FOR HBIM AND ANALYSIS ON PRESERVING A CARAVANSERAI IN KOYSENJAQ
16. COMPARISON OF LEICA BLK360 AND LEICA BLK2GO ON CHOSEN TEST OBJECTS
17. Efficacy evaluation of highly purified intra-articular hyaluronic acid (Sinovial ®) vs hylan G-F20 (Synvisc ®) in the treatment of symptomatic knee osteoarthritis. A double-blind, controlled, randomized, parallel-group non-inferiority study
18. The role of pain and functional impairment in the decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1909 patients. Report of the OARSI-OMERACT Task Force on total joint replacement
19. Brief Report: Association of Rheumatoid Factor and Anti–Citrullinated Protein Antibody Positivity With Better Effectiveness of Abatacept: Results From the Pan-European Registry Analysis
20. MODERN POSSIBILITIES OF DOCUMENTATION AND REPLICATION OF ARCHAEOLOGICAL FINDS
21. SPATIAL 3D DOCUMENTATION OF HISTORICAL MINING REMNANTS IN FORESTED AREA IN THE ERZGEBIRGE/KRUŠNOHOŘÍ MINING REGION UNESCO SITE
22. Novel Approach to Estimate Osteoarthritis Progression: Use of the Reliable Change Index in the Evaluation of Joint Space Loss
23. Serum hyaluronic acid as a potential marker with a predictive value for further radiographic progression of hand osteoarthritis
24. Multi-language translation and cross-cultural adaptation of the OARSI/OMERACT measure of intermittent and constant osteoarthritis pain (ICOAP)
25. A Pooled Analysis Reporting the Efficacy and Safety of Secukinumab in Male and Female Patients with Ankylosing Spondylitis
26. A Pooled Analysis Reporting the Efficacy and Safety of Secukinumab in Male and Female Patients with Ankylosing Spondylitis
27. Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials
28. Circulating miR-145 as a marker of therapeutic response to anti-TNF therapy in patients with ankylosing spondylitis
29. Improving quality of care in rheumatoid arthritis and associated comorbidities
30. Considerations for improving quality of care of patients with rheumatoid arthritis and associated comorbidities
31. Assessment of joint space narrowing with conventional standing antero-posterior radiographs: relief in mild-to-moderate pain is not a confounder in recent osteoarthritis structure-modifying drug trials
32. Increased adiponectin is negatively linked to the local inflammatory process in patients with rheumatoid arthritis
33. Elevated tenascin-C serum levels in patients with axial spondyloarthritis
34. THE CONTRIBUTION OF GEOMATIC TECHNOLOGIES TO BIM
35. Total joint replacement of hip or knee as an outcome measure for structure modifying trials in osteoarthritis
36. Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practice
37. Predictors of DAPSA28 Remission at 6 Months in Bio-Naive Patients with Psoriatic Arthritis Starting a TNF Inhibitor in Clinical Practice-Results from the EuroSpA Collaboration
38. Sustained benefit in rheumatoid arthritis following one course of rituximab: improvements in physical function over 2 years
39. Double-Blind Randomized Controlled Clinical Trial of the Interleukin-6 Receptor Antagonist, Tocilizumab, in European Patients with Rheumatoid Arthritis Who had an Incomplete Response to Methotrexate
40. Therapeutics 1: OP6. SUSTAINED EFFICACY AND SAFETY FOLLOWING A SECOND TREATMENT COURSE OF RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS
41. Measurement of structural progression in osteoarthritis of the hip: the Barcelona consensus group
42. Hyaluronic acid levels may have predictive value for the progression of knee osteoarthritis
43. Smoking and response to rituximab in rheumatoid arthritis:results from an international European collaboration
44. Valdecoxib is as effective as diclofenac in the management of rheumatoid arthritis with a lower incidence of gastroduodenal ulcers: results of a 26-week trial
45. Confirmation of glucosamine sulfate as an osteoarthritis disease modification agent: a long-term, randomized, placebocontrolled, independent trial on knee osteoarthritis progression
46. Relief in mild-to-moderate pain is not a confounder in joint space narrowing assessment of full extension knee radiographs in recent osteoarthritis structure-modifying drug trials
47. Efficacy and Tolerability of Injectable Collagen-Containing Products in Comparison to Trimecaine in Patients With Acute Lumbar Spine Pain (Study FUTURE-MD-Back Pain)
48. Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis
49. Non-pharmacological Effects in Switching Medication: The Nocebo Effect in Switching from Originator to Biosimilar Agent
50. Non-pharmacological Effects in Switching Medication: The Nocebo Effect in Switching from Originator to Biosimilar Agent
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.